Once-daily dosing of aminoglycosides (Q46860894)

25 December 2017

meta-analysis

0 references

title

Once-daily dosing of aminoglycosides (English)

1 reference

25 December 2017

author name string

J Blaser

series ordinal

1

1 reference

25 December 2017

C König

series ordinal

2

1 reference

25 December 2017

publication date

1 December 1995

1 reference

25 December 2017

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

25 December 2017

volume

14

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1029-1038

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/bf01590935

exact match

0 references

cites work

Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.

1 reference

https://api.crossref.org/works/10.1007%2FBF01590935

Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01590935

Single-dose daily gentamicin therapy in urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01590935

Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01590935

[Aminoglycosides in patients with mucoviscidosis and pulmonary exacerbation. Comparison of once or three times daily administration]

21 January 2018

1 reference

12 December 2020

Serum monitoring and practicalities of once-daily aminoglycoside dosing

1 reference

12 December 2020

Aminoglycoside Ototoxicity: Influence of Dosage Regimen on Drug Uptake and Correlation between Membrane Binding and some Clinical Features

1 reference

12 December 2020

Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model

1 reference

12 December 2020

Comparison of once-daily and thrice-daily netilmicin regimens in serious systemic infections: a multicenter study in six Asian countries

1 reference

12 December 2020

Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control

1 reference

12 December 2020

Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs

1 reference

12 December 2020

The post-antibiotic sub-MIC effect in vitro and in vivo

1 reference

12 December 2020

Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model

1 reference

12 December 2020

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia

1 reference

12 December 2020

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

12 December 2020

Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections.

1 reference

12 December 2020

Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis

1 reference

12 December 2020

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

1 reference

12 December 2020

Intravenous administration of gentamicin once daily versus thrice daily in adults

1 reference

12 December 2020

Amikacin, Ceftazidime, and Flucloxacillin against Suspended and Adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an In Vitro Model of Infection

1 reference

12 December 2020

Once versus thrice daily gentamicin in patients with serious infections

1 reference

12 December 2020

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model

1 reference

12 December 2020

Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs

1 reference

12 December 2020

Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection

1 reference

12 December 2020

Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits

1 reference

12 December 2020

Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease

1 reference

12 December 2020

Amikacin once daily plus metronidazole versus amikacin twice daily plus metronidazole in colorectal surgery

1 reference

12 December 2020

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

12 December 2020

A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycin

1 reference

12 December 2020

[Comparison of netilmicin administration once or three times daily in intensive care patients]

1 reference

12 December 2020

Pharmacokinetics and antibacterial activity of daily gentamicin

1 reference

12 December 2020

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

1 reference

12 December 2020

Kinetics of antimicrobial activity

1 reference

12 December 2020

Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis

1 reference

12 December 2020

Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole

1 reference

12 December 2020

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

12 December 2020

Single daily ceftriaxone and tobramycin in the empirical management of febrile neutropenic patients: a randomised trial

1 reference

12 December 2020

Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group.

1 reference

12 December 2020

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

1 reference

12 December 2020

A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients

1 reference

12 December 2020

Multicenter quality control study of amikacin assay for monitoring once-daily dosing regimens. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats

1 reference

12 December 2020

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients

1 reference

12 December 2020

[The single daily dose of gentamicin in the treatment of urinary tract infections (author's transl)]

1 reference

12 December 2020

Postantibiotic suppression of bacterial growth

1 reference

12 December 2020

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

1 reference

12 December 2020

Comparison of the efficacy and safety of amikacin once or twice-a-day in the treatment of severe gram-negative infections in the elderly

1 reference

12 December 2020

Aminoglycoside binding sites in the inner ears of guinea pigs

1 reference

12 December 2020

Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice

1 reference

12 December 2020

Aminoglycoside monitoring in the once- or twice-daily era. The Dutch situation considered

1 reference

12 December 2020

The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess

1 reference

12 December 2020

Studies on drug monitoring in thrice and once daily treatment with aminoglycosides

1 reference

12 December 2020

In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats.

1 reference

12 December 2020

The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure

1 reference

12 December 2020

Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones.

1 reference

12 December 2020

Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity

1 reference

12 December 2020

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

12 December 2020

Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections

1 reference

12 December 2020

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

1 reference

12 December 2020

Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics

1 reference

12 December 2020

Monitoring serum concentrations for once-daily netilmicin dosing regimens

1 reference

12 December 2020

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections

1 reference

12 December 2020

Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients

1 reference

12 December 2020

Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice

1 reference

12 December 2020

Practicalities of once-daily aminoglycoside dosing

1 reference

12 December 2020

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

1 reference

12 December 2020

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin

1 reference

12 December 2020

Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model

1 reference

12 December 2020

First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.

1 reference

12 December 2020

Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage

1 reference

12 December 2020

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01590935

1 reference

25 December 2017

PubMed ID

8681976

1 reference

25 December 2017